Posted by Michael Wonder on 18 Oct 2016
TGA publishes AusPAR for Keytruda
18 October 2016 - The TGA has finally published an AusPAR for MSD's PD-1 inhibitor.
The TGA approved Keytruda on 15 April 2015 for use as monotherapy for the treatment of unresectable or metastatic melanoma in adults.
It is hard to fathom why it has taken 546 days for the AusPAR to be published. The EMA published an EPAR for Keytruda in July 2015.
